Assessment | Measured with | T-1 | T0 | T1 | T2 | T3 |
---|---|---|---|---|---|---|
Coping with itch and disease | JUCKKI-COPECI (8-12Â yr) or JUCKJU-COPEJU (13-18Â yr) [23] | x | x | x | x | x |
Disease-specific quality of life | CDQLI [31] | x | x | x | x | x |
Disease activity and control (AD) | EASI [33] | x | x | x | x | x |
 | SA-EASI [25] | x | x | x | x | x |
 | Used topical corticosteroids | x | x | x | x | x |
 | TARC [34] | x | x | x | x | x |
Disease activity and control (Asthma) | ACQ [35] | x | x | x | x | x |
 | PAQLQ [36] | x |  |  |  | x |
 | Lung function test | x | x | x | x | x |
 | FeNO | x | x | x | x | x |
 | Used medication | x | x | x | x | x |
 | Metacholine provocation | x | x | x | x | x |
Serum | Total IgE | Â | x | Â | Â | x |
 | Specific IgE: inhalation/food: ImmunoCAP |  | x |  |  | x |
 | Specific IgE: inhalation/food: ImmunoCAP ISAC |  | x |  |  |  |
 | Eosinophils |  | x | x | x | x |
 | Cytokine profile |  | x | x | x | x |
Questionnaires | Social demographic information | x | Â | Â | Â | Â |
 | Intelligence test [37] | x |  |  |  |  |
 | x |  |  |  |  | |
 | x |  |  |  |  | |
 | Corticosteroid use | x |  |  | x | x |
 | NPV-J [42] | x |  |  |  |  |
 | TRF [40] | x |  |  |  |  |
 | x |  | x |  | x | |
 | ZBV-K [45] | x | x | x |  | x |
 | PUL (>12 yr) [46] | x |  | x |  | x |
 | Quality of life (parents) [47] | x | x | x |  | x |
 | ZBV [48] | x |  | x |  | x |
 | NOSI-K [49] | x |  | x |  | x |
 | NOSI-events [49] | x |  |  |  | x |
Other | Maximal cycle ergometer test | x | Â | Â | Â | x |
 | Bacterial colonization of the skin |  | x | x | x | x |
 | Bacterial colonization of the nose |  | x | x | x | x |
 | Skin strips for protease activity |  | x | x | x | x |